Skip to content

A prospective randomized controlled study on the effect of multimodal analgesia in patients undergoing gynecological tumor surgery

A prospective randomized controlled study on the effect of multimodal analgesia in patients undergoing gynecological tumor surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029903
Enrollment
Unknown
Registered
2020-02-16
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Multimodal analgesia group:Transversus abdominis plane block combined with paracetamol and non-steroidal anti-inflammatory drugs
Traditional analgesia group:Intravenous opioid analgesia

Sponsors

Department of Anesthesiology, Beijing University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years, ASA I-II; 2. Patients with endometrial, ovarian or cervical cancer who will undertake elective laparotomy under general anesthesia; 3. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Bowel resection is expected during operation 2. Abnormal coagulation function; 3. BMI > 40kg / m2; 4. Skin infection at puncture site of abdominal nerve block; 5. History of Severe hypertension, diabetes mellitus, ischemic heart disease, heart failure and stroke; 6. History of peptic ulcer, bleeding or perforation; 7. Severe hepatorenal insufficiency (creatinine clearance rate 7 points); 8. Allergic history of ropivacaine, paracetamol, NSAID and floxacin; 9. Long term medication history of opioids, monoamine oxidase inhibitors, dicoumarin anticoagulants, selective 5-hydroxytryptamine reuptake inhibitors, or NSAID analgesics; 10. Alcohol addiction or drug abuse before surgery; 11. Unable to understand pain score or verbal communication disorder; 12. Pregnant or lactating patients; 13. Patients who have participated in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Morphine dosage in 24h after surgery;

Secondary

MeasureTime frame
Postoperative analgesia score;Operation of analgesia pump;Dosage of supplementary analgesics;Analgesia satisfaction;Analgesic side effects;Postoperative rehabilitation;Expense during hospital stay;Postoperative 30-day complications;Postoperative 30-day quality of life;

Countries

China

Contacts

Public ContactGeng Zhiyu

Department of anesthesiology, Beijing University First Hospital

gengzhiyu2013@163.com+86 13681121461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026